proto.life feature on industrial manufacture of human cells

This in depth feature in proto.life covers the background to stem cell reprogramming - from Yamanaka's Nobel Prize winning breakthrough to bit.bio's recent presentation at ISSCR of unprecedented consistency data for the manufacture of human cells. 

Read the full piece to find out how this could lead to more accessible and cost-effective cell therapies and regenerative medicines and what external experts in the field are saying about bit.bio's opti-ox^TM technology and its potential.

Access the feature.